The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation.
暂无分享,去创建一个
E. Rosen | I. Goldberg | S. Rockwell | S. Fan | E M Rosen | S Fan | S Rockwell | I D Goldberg | Sara Rockwell | Saijun Fan
[1] M. Urie,et al. Proton beams in radiation therapy. , 1992, Journal of the National Cancer Institute.
[2] D. Goeddel,et al. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 , 1995, Science.
[3] E. Rosen,et al. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents , 1998, Oncogene.
[4] A. Carrano,et al. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange , 1990, Molecular and cellular biology.
[5] H. Lorenz,et al. A rapid and simple method for the isolation of apoptotic DNA fragments. , 1994, Nucleic acids research.
[6] K. Vousden,et al. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function , 1996, Molecular and cellular biology.
[7] G. Nuovo,et al. Hyperexpression of mitogen-activated protein kinase in human breast cancer. , 1997, The Journal of clinical investigation.
[8] G. V. Vande Woude,et al. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability , 1997, Molecular and cellular biology.
[9] J. Rommens,et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.
[10] J. Rossant,et al. The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse , 1996, Cell.
[11] T Takahashi,et al. Overexpression of bax sensitizes human breast cancer MCF‐7 cells to radiation‐induced apoptosis , 1996, International journal of cancer.
[12] K. Caldecott,et al. XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. , 1996, Nucleic acids research.
[13] J. Cleveland,et al. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. , 1996, Oncogene.
[14] D. Hallahan,et al. Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[15] D A Scudiero,et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.
[16] G. Birrell,et al. Induction of p53 protein by gamma radiation in lymphocyte lines from breast cancer and ataxia telangiectasia patients. , 1995, British Journal of Cancer.
[17] M. Greaves,et al. ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block. , 1996, Oncogene.
[18] R. Weichselbaum,et al. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage , 1996, Nature.
[19] R. Muschel,et al. The molecular basis for cell cycle delays following ionizing radiation: a review. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] S. Tucker,et al. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. , 1995, International journal of radiation oncology, biology, physics.
[21] J. Stone,et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.
[22] D. Hallahan,et al. Tumor necrosis factor α (TNF-α) gene therapy targeted by ionizing radiation selectively damages tumor vasculature , 1996 .
[23] C. Snapper,et al. Synergy of IL-1 and stem cell factor in radioprotection of mice is associated with IL-1 up-regulation of mRNA and protein expression for c-kit on bone marrow cells. , 1994, Journal of immunology.
[24] Alfred A. Boyd,et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 , 1996, Nature Genetics.
[25] E. Rosen,et al. Scatter factor and angiogenesis. , 1995, Advances in cancer research.
[26] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[27] I. Wertz,et al. Diverse molecular provocation of programmed cell death. , 1996, Trends in biochemical sciences.
[28] M. Evans,et al. p53 modulation of TFIIH–associated nucleotide excision repair activity , 1995, Nature Genetics.
[29] R. Bristow,et al. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. , 1994, Oncogene.
[30] P. Jeggo,et al. DNA strand break rejoining defect in xrs-6 is complemented by transfection with the human Ku80 gene. , 1995, Cancer research.
[31] E. Shaulian,et al. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. , 1995, Genes & development.
[32] D. Hallahan,et al. c-jun and Egr-1 Participate in DNA Synthesis and Cell Survival in Response to Ionizing Radiation Exposure (*) , 1995, The Journal of Biological Chemistry.
[33] S. Velasco-Miguel,et al. Induction of the growth inhibitor IGF-binding protein 3 by p53 , 1995, Nature.
[34] Ralph Scully,et al. Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage , 1997, Cell.
[35] P. Bergman,et al. Radioresistance, chemoresistance, and apoptosis resistance. The past, present, and future. , 1997, The Veterinary clinics of North America. Small animal practice.
[36] G T Chen,et al. Implementation of three dimensional conformal radiation therapy: prospects, opportunities, and challenges. , 1995, International journal of radiation oncology, biology, physics.
[37] M. Oettinger,et al. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect , 1995, Science.
[38] G. Morris. Review article: effects of radiation on the cell proliferation kinetics of epithelial tissues--therapeutic implications. , 1996, The British journal of radiology.
[39] R. Chakraborty,et al. Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. II. A Mendelian single-locus model of cancer predisposition and radiosensitivity for predicting cancer risks in populations. , 1995, Radiation research.
[40] S. Hellman,et al. Normal tissue responses to radiation therapy. , 1975, The New England journal of medicine.
[41] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[42] E. Rosen,et al. Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction , 1994, The Journal of cell biology.
[43] K. Kohn,et al. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. , 1993, Cancer research.
[44] G. Fletcher. Textbook of radiotherapy , 1973 .
[45] C. Rodríguez,et al. Interleukin‐1β suppresses apoptosis in CD34 positive bone marrow cells through activation of the type I IL‐1 receptor , 1996, Journal of cellular physiology.
[46] D. Vaux,et al. CED-4—The Third Horseman of Apoptosis , 1997, Cell.
[47] M. Sklar. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. , 1988, Science.
[48] S. Frisch,et al. Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.
[49] K. Nakagawa,et al. Radiation therapy for patients with xeroderma pigmentosum. , 1996, Radiation medicine.
[50] J. Rubin,et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.
[51] G. H. Weiss,et al. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. , 1997, The Journal of urology.
[52] M. Arends,et al. Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter its clonogenic survival dose-response. , 1995, British Journal of Cancer.
[53] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[54] K. Kohn,et al. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. , 1995, Cancer research.
[55] L. Peters. Radiation therapy tolerance limits: For one or for all?‐Janeway lecture , 1996, Cancer.
[56] R. Weichselbaum,et al. Expression of the polymorphic human DNA repair gene XRCC1 does not correlate with radiosensitivity in the cells of human head and neck tumor cell lines. , 1992, Radiation research.
[57] J Isola,et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. , 1997, Cancer research.
[58] D. Murray,et al. The importance of the ERCC1/ERCC4[XPF] complex for hypoxic-cell radioresistance does not appear to derive from its participation in the nucleotide excision repair pathway. , 1996, Mutation research.
[59] H. Thames,et al. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. , 1997, International journal of radiation oncology, biology, physics.
[60] S. Sawada,et al. Radiation-induced apoptosis and necrosis in Molt-4 cells: a study of dose-effect relationships and their modification. , 1993, International journal of radiation biology.
[61] John Calvin Reed. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. , 1995, Current opinion in oncology.
[62] L. Hartwell,et al. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. , 1988, Science.
[63] E. Sausville,et al. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. , 1996, Journal of the National Cancer Institute.
[64] T. Wheldon,et al. The effect of irradiation on function in self-renewing normal tissues with differing proliferative organisation. , 1982, The British journal of radiology.
[65] J. Michaeli,et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. , 1994, Cancer research.
[66] C. Ling,et al. Synergistic effect of the v-myc oncogene with H-ras on radioresistance. , 1990, Cancer research.
[67] A. Klippel,et al. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.
[68] P. Thong,et al. Sequestration of mitotic (M‐phase) chromosomes in autophagosomes: Mitotic programmed cell death in human Chang liver cells induced by an OH* burst from vanadyl(4) , 1996, The Anatomical record.
[69] M. Karin,et al. Three distinct signalling responses by murine fibroblasts to genotoxic stress , 1996, Nature.
[70] Marlys Witte,et al. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells , 1998, International journal of cancer.
[71] D. Brachman,et al. Cellular and molecular mechanisms of radioresistance. , 1995, Cancer treatment and research.
[72] Y. Shiloh,et al. Predominance of null mutations in ataxia-telangiectasia. , 1996, Human molecular genetics.
[73] J. Abrams,et al. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor , 1992, The Journal of experimental medicine.
[74] H. Suit. Assessment of the impact of local control on clinical outcome. , 1996, Frontiers of radiation therapy and oncology.
[75] R. Cowan,et al. Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. , 1995, International journal of radiation biology.
[76] A. Markoe,et al. Radioresistance in murine solid tumors induced by interleukin-1. , 1996, Radiation research.
[77] R. Muschel,et al. The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts. , 1996, Cancer research.
[78] Yonghong Xiao,et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.
[79] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[80] D. Hallahan,et al. The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. , 1990, International journal of radiation oncology, biology, physics.
[81] G. Birrell,et al. Normal tissue radiosensitivity in breast cancer patients. , 1995, International journal of radiation oncology, biology, physics.
[82] Amanda G Paulovich,et al. When Checkpoints Fail , 1997, Cell.
[83] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[84] C. S. Freitas,et al. Interleukin-1 and tumor necrosis factor-alpha as radio- and chemoprotectors of bone marrow. , 1993, Bone marrow transplantation.
[85] S. Roberts,et al. Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predisposition. , 1996, Radiation research.
[86] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[87] D. Baltimore,et al. Dual roles of ATM in the cellular response to radiation and in cell growth control. , 1996, Genes & development.
[88] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[89] M N Pollak,et al. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women , 1997, Cancer.
[90] F. Collins,et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. , 1995, Human molecular genetics.
[91] L. Chodosh,et al. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[92] H. Withers,et al. Late radiation response of kidney assayed by tubule-cell survival. , 1986, The British journal of radiology.
[93] J C Reed,et al. Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.
[94] Eugene V. Koonin,et al. …Functional motifs… , 1996, Nature Genetics.
[95] D. Thorley-Lawson,et al. A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.
[96] G. Eichele,et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.
[97] J. Kajstura,et al. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. , 1995, Cancer research.
[98] P. O'Connor,et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. , 1994, Science.
[99] J. L. Roti,et al. DNA supercoiling changes and nuclear matrix-associated proteins: possible role in oncogene-mediated radioresistance. , 1996, International journal of radiation oncology, biology, physics.
[100] G. Evan,et al. c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.
[101] A. Bardelli,et al. HGF receptor associates with the anti‐apoptotic protein BAG‐1 and prevents cell death. , 1996, The EMBO journal.
[102] J. Dunst,et al. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?]. , 1995, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[103] D A Pierce,et al. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. , 1996, Radiation research.
[104] R. Weichselbaum,et al. Loss of ceramide production confers resistance to radiation-induced apoptosis. , 1997, Cancer research.
[105] B. Dörken,et al. Expression of the bcl‐2 gene family in normal and malignant breast tissue: Low bax‐α expression in tumor cells correlates with resistance towards apoptosis , 1995, International journal of cancer.
[106] A. Joseph,et al. Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations. , 1996, The American journal of pathology.
[107] S. Hellman,et al. Stem cell depletion: an explanation of the late effects of cytotoxins. , 1977, International journal of radiation oncology, biology, physics.
[108] Junying Yuan,et al. Functional role of interleukin 1 beta (IL-1 beta) in IL-1 beta- converting enzyme-mediated apoptosis , 1996, The Journal of experimental medicine.
[109] G. Evan,et al. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis , 1997, Molecular and cellular biology.
[110] V. Dixit,et al. Type I Insulin-like Growth Factor Receptor Activation Regulates Apoptotic Proteins* , 1996, The Journal of Biological Chemistry.
[111] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[112] M. Ogawa,et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. , 1994, Cancer research.
[113] J. Greenberger,et al. Effects of recombinant cytokines on colony formation by irradiated human cord blood CD34+ hematopoietic progenitor cells. , 1997, Radiation research.
[114] C. Land. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer. , 1995, JAMA.
[115] Y. Shiloh,et al. Fragments of ATM which have dominant-negative or complementing activity , 1997, Molecular and cellular biology.
[116] M. Lovett,et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.
[117] S. Sukumar,et al. Mutations in p53 as potential molecular markers for human breast cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.